PanCAN Japan Receives the 77th Health and Culture Award

PanCAN Japan is honored to announce that we have received the Group Award at the 77th Health and Culture Awards, hosted by the Ministry of Health, Labour and Welfare and Dai-ichi Life Insurance Company.

This prestigious award recognizes organizations and individuals who have made outstanding contributions to improving public health and hygiene. We are deeply honored that our activities have received this societal recognition.

 

Award Announcement

On November 19, 2025, at the presentation ceremony held at the Meiji Memorial Hall, PanCAN Japan was awarded the Group Award.

This honor recognizes our activities supporting pancreatic cancer patients and their families, promoting early detection awareness, and advancing research.

 

 

 

Furthermore, on the following day, November 20, World Pancreatic Cancer Day, we were honored to be granted an audience with Their Majesties the Emperor and Empress, and received warm words from Their Majesties.

This event was featured on the Imperial Household Agency's official Instagram and in a Sankei Shimbun news article. Please take a look.

- Click here for the Imperial Household Agency official Instagram photo (Instagram registration required)

- Click here for the Sankei Shimbun article (The photo of The Majesties and Mr. Majima - the Imperial Household Agency)

Words of Gratitude

This award would not have been possible without the support of the Honorary Chairman, Chairman, Honorary Members, and Special Members of the Japan Pancreatic Society.

We express our deepest gratitude to all the professors, especially Professor Hanada, the first recipient of the PanCAN Award, for their tremendous efforts.

We also believe this achievement is the result of the combined strength of all PanCAN Japan branches nationwide and the entire pancreatic cancer community.

This award is not just for us, but for the entire Japanese pancreatic cancer community.

Future Activities

Inspired by this award, PanCAN Japan will continue working alongside the PanCAN headquarters, the Ministry of Health, Labour and Welfare, the Japan Pancreatic Society, and pharmaceutical companies as a member of the pancreatic cancer community. We will strive to double the five-year survival rate for pancreatic cancer by 2030. We will convey the voices of patients and their families to society and contribute to the further advancement of research and medical care.

We sincerely ask for your continued support and cooperation moving forward.